Bio-Rad Laboratories, Inc. is a healthcare company.
Bio-Rad Laboratories, Inc. (BIO) is expected to report earnings on Thursday, October 29, 2026, after the close. Estimated release time 16:17 ET. Consensus EPS estimate is $2.23.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-04-30 | FY2026 Q1 | $1.97 | $1.89 | -4.1% | $592.10M |
| 2025-10-29 | FY2025 Q3 | $2.30 | $2.26 | -1.7% | $653.00M |
| 2025-05-01 | FY2025 Q1 | $1.73 | $2.29 | +32.4% | $585.40M |
| 2025-02-14 | FY2024 Q4 | $2.86 | $2.90 | +1.4% | $667.48M |
| 2024-08-02 | FY2024 Q2 | $2.12 | $3.11 | +46.7% | $638.48M |
| 2023-10-27 | FY2023 Q3 | $2.87 | $3.65 | +27.2% | $632.12M |
| 2023-08-04 | FY2023 Q2 | $2.55 | $3.00 | +17.6% | $681.11M |
| 2023-05-05 | FY2023 Q1 | $3.24 | $2.33 | -28.1% | $676.84M |
BIO has beaten consensus EPS in 5 of its last 8 reported quarters.
See BIO on the live calendar →